GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » 3-Year Revenue Growth Rate

Biomaxima (WAR:BMX) 3-Year Revenue Growth Rate : -8.80% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Biomaxima 3-Year Revenue Growth Rate?

Biomaxima's Revenue per Share for the three months ended in Dec. 2023 was zł3.18.

During the past 12 months, Biomaxima's average Revenue per Share Growth Rate was -66.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -8.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Biomaxima was 58.00% per year. The lowest was -8.80% per year. And the median was 11.90% per year.


Competitive Comparison of Biomaxima's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Biomaxima's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomaxima's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Biomaxima's 3-Year Revenue Growth Rate falls into.



Biomaxima 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Biomaxima  (WAR:BMX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Biomaxima 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Biomaxima's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomaxima (WAR:BMX) Business Description

Traded in Other Exchanges
Address
5 Vetterow Street, Lublin, POL, 20-277
Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Biomaxima (WAR:BMX) Headlines

No Headlines